Your browser doesn't support javascript.
loading
Risperidone versus placebo for schizophrenia.
Rattehalli, Ranganath D; Zhao, Sai; Li, Bao Guo; Jayaram, Mahesh B; Xia, Jun; Sampson, Stephanie.
Afiliação
  • Rattehalli RD; General Psychiatry, Logan Hospital, Meadowbrook, Brisbane, Australia, QLD 4131.
  • Zhao S; Systematic Review Solutions Ltd, 5-6 West Tashan Road, Yan Tai, Tianjin, China, 264000.
  • Li BG; Interventional therapy department, Tianjin Medical University Cancer Institute and Hospital, Huan-Hu-Xi Road, Ti-Yuan-Bei,He Xi District, Tianjin, China, 300060.
  • Jayaram MB; Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Australia.
  • Xia J; Cochrane Schizophrenia Group, The University of Nottingham, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road,, Nottingham, UK, NG7 2TU.
  • Sampson S; The University of Nottingham, Institute of Mental Health, University of Nottingham Innovation Park, Jubilee Campus, Nottingham, UK, NG7 2TU.
Cochrane Database Syst Rev ; 12: CD006918, 2016 12 15.
Article em En | MEDLINE | ID: mdl-27977041
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Risperidona Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Risperidona Idioma: En Ano de publicação: 2016 Tipo de documento: Article